Literature DB >> 30824197

Semaphorins as Regulators of Phenotypic Plasticity and Functional Reprogramming of Cancer Cells.

Sreeharsha Gurrapu1, Luca Tamagnone2,3.   

Abstract

Semaphorins, initially found as neuronal guidance cues in embryo development, are now appreciated as major regulators of tissue morphogenesis and homeostasis, as well as of cancer progression. In fact, semaphorin signals have a profound impact on cell morphology, which has been commonly associated with the ability to regulate monomeric GTPases, cell-substrate adhesion, and cytoskeletal dynamics. Recently, however, several reports have indicated a novel and additional function of diverse semaphorins in the regulation of gene expression and cell phenotype plasticity. In this review article, we discuss these novel findings, focusing on the role of semaphorin signals in the regulation of bi-directional epithelial-mesenchymal transitions, stem cell properties, and drug resistance, which greatly contribute to the pathogenesis of cancer.
Copyright © 2019 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Cancer; EMT; drug resistance; neuropilin; plexin; semaphorin; stem cell

Mesh:

Substances:

Year:  2019        PMID: 30824197     DOI: 10.1016/j.molmed.2019.01.010

Source DB:  PubMed          Journal:  Trends Mol Med        ISSN: 1471-4914            Impact factor:   11.951


  11 in total

1.  Semaphorin 4C promotes motility and immunosuppressive activity of cancer cells via CRMP3 and PD-L1.

Authors:  Yu-Hsuan Hung; Ming-Derg Lai; Wen-Chun Hung; Li-Tzong Chen
Journal:  Am J Cancer Res       Date:  2022-02-15       Impact factor: 6.166

Review 2.  Key promoters of tumor hallmarks.

Authors:  Keywan Mortezaee; Jamal Majidpoor
Journal:  Int J Clin Oncol       Date:  2021-11-13       Impact factor: 3.402

Review 3.  Semaphorins as emerging clinical biomarkers and therapeutic targets in cancer.

Authors:  Roberta Mastrantonio; Hua You; Luca Tamagnone
Journal:  Theranostics       Date:  2021-01-15       Impact factor: 11.556

4.  Plexin-B3 Regulates Cellular Motility, Invasiveness, and Metastasis in Pancreatic Cancer.

Authors:  Sugandha Saxena; Dipakkumar R Prajapati; Paran Goel; Babita Tomar; Yuri Hayashi; Pranita Atri; Satyanarayana Rachagani; Paul M Grandgenett; Michael A Hollingsworth; Surinder K Batra; Rakesh K Singh
Journal:  Cancers (Basel)       Date:  2021-02-16       Impact factor: 6.575

Review 5.  SEMAPHORINS and their receptors: focus on the crosstalk between melanoma and hypoxia.

Authors:  Elisabetta Valentini; Marta Di Martile; Donatella Del Bufalo; Simona D'Aguanno
Journal:  J Exp Clin Cancer Res       Date:  2021-04-15

6.  Mechanochemical control of epidermal stem cell divisions by B-plexins.

Authors:  Chen Jiang; Ahsan Javed; Laura Kaiser; Michele M Nava; Rui Xu; Dominique T Brandt; Dandan Zhao; Benjamin Mayer; Javier Fernández-Baldovinos; Luping Zhou; Carsten Höß; Kovilen Sawmynaden; Arkadiusz Oleksy; David Matthews; Lee S Weinstein; Heidi Hahn; Hermann-Josef Gröne; Peter L Graumann; Carien M Niessen; Stefan Offermanns; Sara A Wickström; Thomas Worzfeld
Journal:  Nat Commun       Date:  2021-02-26       Impact factor: 14.919

Review 7.  Nerve density in cancer: Less is better.

Authors:  Ligia B Schmitd; Cindy Perez-Pacheco; Nisha J D'Silva
Journal:  FASEB Bioadv       Date:  2021-07-11

8.  SEMA6B Overexpression Predicts Poor Prognosis and Correlates With the Tumor Immunosuppressive Microenvironment in Colorectal Cancer.

Authors:  Tiegang Li; Zheng Yan; Weiqi Wang; Rixin Zhang; Wenqiang Gan; Silin Lv; Zifan Zeng; Yufang Hou; Min Yang
Journal:  Front Mol Biosci       Date:  2021-12-06

9.  Semaphorin 6C Suppresses Proliferation of Pancreatic Cancer Cells via Inhibition of the AKT/GSK3/β-Catenin/Cyclin D1 Pathway.

Authors:  Yu-Hsuan Hung; Shih-Han Hsu; Ya-Chin Hou; Pei-Yi Chu; Yung-Yeh Su; Yan-Shen Shan; Wen-Chun Hung; Li-Tzong Chen
Journal:  Int J Mol Sci       Date:  2022-02-26       Impact factor: 5.923

10.  TET2-mediated epigenetic reprogramming of breast cancer cells impairs lysosome biogenesis.

Authors:  Audrey Laurent; Thierry Madigou; Maud Bizot; Marion Turpin; Gaëlle Palierne; Elise Mahé; Sarah Guimard; Raphaël Métivier; Stéphane Avner; Christine Le Péron; Gilles Salbert
Journal:  Life Sci Alliance       Date:  2022-03-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.